Ieq Capital LLC, a financial investment firm, has recently acquired a new stake in Axon Enterprise Inc. (AXON:NSD). According to the latest Form 13F filing with the Securities and Exchange Commission, Ieq Capital LLC bought 1,230 shares of Axon stock worth approximately $204,000 during the fourth quarter of the previous year.
Hedge Funds & Institutional Holdings:
Apart from Ieq Capital LLC, other hedge funds have also purchased and sold shares of Axon stock during the same period. The U.S. Capital Wealth Advisors LLC purchased a new stake in Axon Enterprise worth $29,000.
North Star Investment Management Corp. and Accurate Wealth Management LLC both acquired new stakes in the company worth $41,000 and $49,000, respectively.
IFP Advisors Inc. also increased its position in the company by 36.8% during the third quarter and now owns 364 shares worth $28,000.
Lastly, Covestor Ltd. grew its position in Axon Enterprise by 1,125.7% during the first quarter and now owns 429 shares worth $59,000.
Institutional investors and hedge funds own 75.62% of Axon stock.
In other news, Axon Enterprise CEO Patrick W. Smith sold 53,431 shares of Axon stock in a transaction dated March 30th, 2023. The shares were sold at an average price of $217.35, resulting in a total transaction value of $11,613,227.85. Following the sale, Smith now directly owns 2,883,023 shares of the company’s stock worth $626,625,049.05.
Another insider, Director Michael Garnreiter, sold 5,000 shares of the stock in a transaction dated February 2nd, 2023, at an average price of $200.02, for a total value of $1,000,100.00.
Insiders have sold a total of 104,290 shares of company stock worth $22,547,905 over the past three months. Currently, insiders own 6.90% of Axon stock.
Axon Stock-Analyst Ratings:
Several analysts have recently issued reports on Axon stock. Barclays raised their target price on the shares from $177.00 to $222.00 and gave the stock an “overweight” rating in a research note on March 2nd, 2023.
JPMorgan Chase & Co. lowered the shares from an “overweight” rating to a “neutral” rating and set a $224.00 target price for the company on the same day.
The Goldman Sachs Group started coverage on the shares of Axon Enterprise on March 7th, 2023, issuing a “buy” rating and a $263.00 target price for the company.
Robert W. Baird also raised their target price on the shares from $200.00 to $237.00 and gave the stock an “outperform” rating in a research note on March 1st, 2023.
Lastly, Raymond James lowered the shares from a “strong-buy” rating to an “outperform” rating and set a $223.00 target price for the company on February 17th, 2023.
Axon Enterprise Price Performance:
AXON opened at $216.00 on Tuesday. The firm has a market cap of $15.96 billion, a P/E ratio of 105.88, and a beta of 0.95. Axon Enterprise, Inc. has a fifty-two week low of $82.49 and a fifty-two week high of $229.00.
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.66, and a current ratio of 3.00. The firm has a 50-day moving average of $217.33 and a 200-day moving average of $190.01.
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER.
The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.